Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,678.00
Bid: 10,688.00
Ask: 10,690.00
Change: -64.00 (-0.60%)
Spread: 2.00 (0.019%)
Open: 10,756.00
High: 10,780.00
Low: 10,674.00
Prev. Close: 10,742.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-EU warns Hungary against use of Russia's COVID-19 vaccine

Thu, 19th Nov 2020 15:54

* Tensions with Hungary's Orban rising before EU summit

* Hungary to be first EU country to import, trial Sputnik V

* EU: Move raises concerns for safety, confidence in vaccine
(Adds first imports, comment from Hungarian foreign minister)

By Francesco Guarascio

BRUSSELS, Nov 19 (Reuters) - Hungary's plans to import and
possibly use Russia's touted Sputnik V COVID-19 vaccine raise
safety concerns and could damage trust in potential shots, the
European Commission said, opening a new front in the EU's
fraught relations with Budapest.

Hungarian Prime Minister Viktor Orban's hard line against
migration and what critics say is his increasingly authoritarian
grip on power - an accusation he has repeatedly denied - as well
as his pursuit of close relations with Russia have caused
repeated clashes with the European Union.

A new showdown is expected on Thursday when EU leaders hold
a video conference that may address the bloc's massive COVID
rescue plan and seven-year budget, which Hungary and Poland's
nationalist governments are blocking because they make access to
money conditional on respecting the rule of law.

Hungarian plans to conduct trials of and possibly produce
the Russian vaccine, an unprecedented step for an EU member
state, add to existing frictions with Brussels.

Asked about these plans, a spokesman for the Commission, the
EU's executive, said: "The question arises whether a member
state would want to administer to its citizens a vaccine that
has not been reviewed by EMA."

Under EU rules, Sputnik V must be authorised by the European
Medicines Agency before it can be marketed in any state of the
27-nation bloc, EMA said.

"This is where the authorisation process and vaccine
confidence meet. If our citizens start questioning the safety of
a vaccine, should it not have gone through rigorous scientific
assessment to prove its safety and efficacy, it will be much
harder to vaccinate a sufficient proportion of the population,"
the Commission spokesman added in an emailed statement.

A recent study of 8,000 people in the United States and
Britain found that fewer people would "definitely" take a
COVID-19 vaccine than the 55% of the population which scientists
estimate is needed to provide so-called herd immunity
.

Experts have said that misinformation and perceived weak
safety checks on candidate vaccines play a central role in
reducing confidence in their efficacy.

Hungary on Thursday imported the first doses of Sputnik V as
part of a plan that could lead to larger imports and domestic,
mass production next year if the shot proves safe and effective.

"Hungarian experts will have the opportunity to study the
vaccine in the forthcoming period and make a well-founded
decision on potential usability and approval," Foreign Minister
Peter Szijjarto said in a Facebook video.

The government did not respond to questions on whether it
wanted to licence the Sputnik V vaccine at home or through the
required EU process.

Russia's sovereign wealth fund said last week that interim
trial results showed Sputnik V is 92% effective at protecting
people from the COVID-19 respiratory disease, and the country is
preparing for mass inoculations.

Vaccines being developed by U.S. firms Moderna and
Pfizer - the latter in cooperation with Germany's
BioNTech - have showed slightly better
results on a much larger sample of people exposed to the virus.

"Vaccines should be out of politics and countries should
have a choice how to protect their citizens," said Kirill
Dmitriev, head of the Russian sovereign wealth fund which has
underwritten the development of Sputnik V.

He added that Russia was ready to share data with the
European Medicines Agency and said it aimed to produce the
vaccine in Hungary and in other willing EU nations. A subsidiary
of the wealth fund also requested scientific advice from EMA in
late October but has received no reply so far, the fund said.

EMA said that it had received no data from Russia or Hungary
on Sputnik V or any other COVID-19 vaccine.

Sputnik V is expected to be trialled and produced in other
countries across the world beyond Russia, with Brazil, Mexico,
the Philippines and the United Arab Emirates among those who
have expressed an interest in the shot.

IMPORT DOUBTS

But the EU questions even the import of Sputnik V by one of
its member states.

Temporary import and distribution of unauthorised vaccines
is allowed for emergency use in the EU "in response to the
suspected or confirmed spread of pathogenic agents, toxins,
chemical agents or nuclear radiation, any of which could cause
harm," the relevant EU law reads.

This rare exemption has been subjected to scrutiny in recent
months by EU experts, the Commission said. "The widely supported
view is that it should be considered very carefully," its
spokesman said. Such emergency procedures, he added, would also
conflict with the EU's current vaccine strategy.

Under that strategy, the EU has signed contracts with five
vaccine makers, including Pfizer, for the supply of nearly 2
billion doses of their potential COVID vaccines and is talking
with at least two other manufacturers for additional shots.

That would cover the 450 million combined population of all
EU states, including Hungary, which under those deals also
ordered millions of doses of the Pfizer, AstraZeneca and
Johnson & Johnson vaccines now in development.
(Reporting by Francesco Guarascio @fraguarascio in Brussels
with additional reporting by Marton Dunai in Budapest and Polina
Nikolskaya in Moscow
Editing by Mark Heinrich)

More News
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.